Table 3.
Univariate | Model1 | Model2 | ||||
---|---|---|---|---|---|---|
OR | P | OR | P | OR | P | |
Men | ||||||
Q1 | 8.18(3.78–17.70) | 0.00 | 3.30(1.40–7.80) | 0.01 | 4.33(1.06–17.78) | 0.04 |
Q2 | 2.58(1.17–5.68) | 0.02 | 1.40(0.59–3.30) | 0.44 | 1.25(0.32–4.92) | 0.75 |
Q3 | 1(reference) | – | 1 | – | 1 | – |
Women | ||||||
Q1 | 6.78(2.93–15.69) | 0.00 | 3.63(1.45–9.10) | 0.01 | 4.66(1.06–20.57) | 0.04 |
Q2 | 3.33(1.54–7.20) | 0.00 | 1.96(0.84–4.53) | 0.12 | 3.60(1.00–12.91) | 0.05 |
Q3 | 1 | – | 1 | – | 1 | – |
Model1: adjusted for age
Model2: further adjusted for duration diabetes, duration of hypertension, BMI, waist, SBP, DBP, HbA1c, smoker, alcohol, FINS, uric, TC, TG, HDL-C, LDL-C
Abbreviations: SVR skeletal muscle mass to visceral fat area ratio, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FINS fasting serum insulin, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol